Key result
Mild encephalitis with a reversible splenial lesion linked to anti-glutamate receptor antibodies resolves within 3 months.
Why the study?
The role of anti-glutamate epsilon2 receptor antibodies in clinically mild encephalitis/encephalopathy with reversible splenial lesion and prolonged seizures is unclear.
Case Report (n=1)
Anti-glutamate epsilon2 receptor antibodies may be associated with prolonged generalized seizures and play a role in the pathogenesis of clinically mild encephalitis/encephalopathy with a reversible splenial lesion.
May support anti-GluR antibody testing in select MERS cases; hypothesis-generating and should not yet change practice.
We report the case of an 18-year-old boy who presented with disturbance of consciousness and generalized seizures following flu-like symptoms such as high fever and arthralgia. T2 and diffusion weighted brain magnetic resonance images showed a hyperintense ovoid lesion in the splenium of the corpus callosum and T, weighted images showed a hypointense lesion; the lesion completely disappeared on repeat imaging after 3 days. Antiglutamate epsilon2 receptor antibodies were detected in his cerebrospinal fluid. Although the patient had several episodes of generalized seizures, he completely recovered within 3 months. Our patient had a clinically mild encephalitis/encephalopathy with a reversible splenial lesion following flu-like symptoms, which indicated viral infection. As compared to previously reported cases, our case was characteristic because of the protracted recovery shown by the patient. Anti-glutamate epsilon2 receptor antibodies may be associated with prolonged generalized seizures in the case of our patient. Our results also suggest that anti-glutamate epsilon2 receptor antibodies may play a role in the pathogenesis of this condition.
No takes yet. Share an insight, caveat, or question.
Fujiki et al. (2011) conducted a case report in Clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) (n=1). Anti-glutamate receptor antibodies was evaluated on Clinical recovery and lesion resolution. A 19-year-old boy with clinically mild encephalitis/encephalopathy with a reversible splenial lesion associated with anti-glutamate receptor antibodies completely recovered within 3 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: